{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:56:06Z","timestamp":1791395766858,"version":"4.3.3"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200670;  81570826"],"award-info":[{"award-number":["81200670;  81570826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,6,10]]},"abstract":"<jats:sec>\n<jats:title>Purpose:<\/jats:title>\n<jats:p>Oxidative stress to retinal pigment epithelial (RPE) cells and\ninflammation are closely related to the pathogenesis of age-related macular\ndegeneration (AMD). Celastrol is a natural compound isolated from the root of\nTripterygium wilfordii. Celastrol has been shown to have potent anti-inflammatory and\nanti-tumor effects in multiple disease models. The objective of this study was to test the\nanti-oxidative effects of celastrol in RPE cells and to investigate the underlying\nmechanisms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>ARPE-19 cells were treated with hydrogen peroxide (H2O2) and menadione\nalone or in combination with celastrol. Cell viability and apoptosis were examined by\nCCK-8 and TUNEL assay, respectively. The expression of Nrf2 and its target genes,\nsuch as GCLM and HO-1 was determined by Western blotting. The knockdown of Nrf2\nwas done by transfecting ARPE-19 cells with lentivirus encoding shRNA against Nrf2.\nThe knockdown efficiency was determined by real-time quantitative PCR and Western\nblotting.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Treatment of ARPE-19 cells with celastrol significantly attenuated the toxic\neffects of both H2O2 and menadione. Treatment with celastrol enhanced the expression\nof transcription factor Nrf2 and its targets, GCLM and HO-1. Knockdown of Nrf2\nexpression by shRNA partially abolished the protective effects of celastrol. Chemical\ninhibition of glutathione synthesis by L-buthionine-S,R-sulfoximine (BSO) completely\nabolished the protective effects of celastrol against H2O2 and menadione-induced\ndamage. However, chemical inhibition of HO-1 activity by ZnPPIX did not reduce the\nprotective effects of celastrol.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study provides evidence that treatment of RPE cells with celastrol\nshows potent protective effects against oxidative insults via activation of Nrf2 signaling\npathway and upregulation of GCLM expression. This finding suggests that celastrol\nmight be used as a potential therapeutic agent for oxidative stress-related eyes\ndiseases, such as AMD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524019666190424131704","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T08:40:21Z","timestamp":1556527221000},"page":"172-182","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Celastrol Protects RPE Cells from Oxidative Stress-Induced Cell Death via Activation of Nrf2 Signaling Pathway"],"prefix":"10.2174","volume":"19","author":[{"given":"Yeqi","family":"Zhou","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbin","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewen","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Shang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"Wong W.L.","year":"2014","unstructured":"Wong WL, Su X, Li X.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","journal-title":"Lancet Glob Health"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.22608\/APO2017416","volume":"6","author":"Singh N.","year":"2017","unstructured":"Singh N, Srinivasan S, Muralidharan V, Roy R.  v J, Raman R. Prevention of Age-Related Macular Degeneration.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","volume":"45","author":"Beatty S.","year":"2000","unstructured":"Beatty S, Koh H, Phil M, Henson D, Boulton M.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.","journal-title":"Surv Ophthalmol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3934\/molsci.2016.2.196","volume":"3","author":"Shaw P.X.","year":"2016","unstructured":"Shaw PX, Stiles T, Douglas C.  Oxidative stress, innate immunity, and age-related macular degeneration.","journal-title":"AIMS Mol Sci"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.exer.2005.01.007","volume":"80","author":"Sparrow J.R.","year":"2005","unstructured":"Sparrow JR, Boulton M.  RPE lipofuscin and its role in retinal pathobiology.","journal-title":"Exp Eye Res"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41419-017-0200-7","volume":"9","author":"Wang J.","year":"2018","unstructured":"Wang J, Feng Y, Han P.  Photosensitization of A2E triggers telomere dysfunction and accelerates retinal pigment epithelium senescence.","journal-title":"Cell Death Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"Datta S.","year":"2017","unstructured":"Datta S, Cano M, Ebrahimi K, Wang L, Handa JT.  The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.","journal-title":"Prog Retin Eye Res"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"Bhutto I.","year":"2012","unstructured":"Bhutto I, Lutty G.  Understanding age-related macular dege-neration (AMD): relationships between the photoreceptor\/ retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex.","journal-title":"Mol Aspects Med"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.4266","volume":"232","author":"van Lookeren Campagne M.","year":"2014","unstructured":"van Lookeren Campagne M, LeCouter J, Yaspan BL, Ye W.  Mechanisms of age-related macular degeneration and therapeutic opportunities.","journal-title":"J Pathol"},{"key":"ref=10","first-page":"2040","volume":"17","author":"Dong X.","year":"2011","unstructured":"Dong X, Li Z, Wang W.  Protective effect of canolol from oxidative stress-induced cell damage in ARPE-19 cells via an ERK mediated antioxidative pathway.","journal-title":"Mol Vis"},{"key":"ref=11","first-page":"1656","volume":"19","author":"Li Z.","year":"2013","unstructured":"Li Z, Dong X, Liu H.  Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K\/Akt.","journal-title":"Mol Vis"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12967-018-1434-6","volume":"16","author":"Inana G.","year":"2018","unstructured":"Inana G, Murat C, An W, Yao X, Harris IR, Cao J.  RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells.","journal-title":"J Transl Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-319-41334-1_12","volume":"928","author":"Venkatesha S.H.","year":"2016","unstructured":"Venkatesha SH, Moudgil KD.  Celastrol and its role in controlling chronic diseases.","journal-title":"Adv Exp Med Biol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fmed.2017.00069","volume":"4","author":"Casc\u00e3o R.","year":"2017","unstructured":"Casc\u00e3o R, Fonseca JE, Moita LF.  Celastrol: A spectrum of treatment opportunities in chronic diseases.","journal-title":"Front Med (Lausanne)"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/femspd\/ftw059","volume":"74","author":"Venkatesha S.H.","year":"2016","unstructured":"Venkatesha SH, Dudics S, Astry B, Moudgil KD.  Control of autoimmune inflammation by celastrol, a natural triterpenoid.","journal-title":"Pathog Dis"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2014.09.001","volume":"742","author":"Abdin A.A.","year":"2014","unstructured":"Abdin AA, Hasby EA.  Modulatory effect of celastrol on Th1\/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.","journal-title":"Eur J Pharmacol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1566524015666150505160743","volume":"15","author":"Yu Y.","year":"2015","unstructured":"Yu Y, Koehn CD, Yue Y.  Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation.","journal-title":"Curr Mol Med"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-7-17","volume":"7","author":"Paris D.","year":"2010","unstructured":"Paris D, Ganey NJ, Laporte V.  Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer\u2019s disease.","journal-title":"J Neuroinflammation"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3233\/JAD-131799","volume":"41","author":"Zhao Y.","year":"2014","unstructured":"Zhao Y, Zhao H, Lobo N, Guo X, Gentleman SM, Ma D.  Celastrol enhances cell viability and inhibits amyloid-\u03b2 production induced by lipopolysaccharide","journal-title":"J Alzheimers Dis"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11064-013-1193-y","volume":"39","author":"Choi B.S.","year":"2014","unstructured":"Choi BS, Kim H, Lee HJ.  Celastrol from \u2018Thunder God Vine\u2019 protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson\u2019s disease.","journal-title":"Neurochem Res"},{"key":"ref=21","first-page":"751","volume":"69","author":"Li Y.H.","year":"2017","unstructured":"Li YH, Liu SB, Zhang HY.  Antioxidant effects of celastrol against hydrogen peroxide-induced oxidative stress in the cell model of amyotrophic lateral sclerosis.","journal-title":"Sheng Li Xue Bao"},{"key":"ref=22","volume":"8","author":"Gu L.","year":"2013","unstructured":"Gu L, Bai W, Li S.  Celastrol prevents atherosclerosis  inhibiting LOX-1 and oxidative stress.","journal-title":"PLoS One"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2015.08.005","volume":"22","author":"Ma X.","year":"2015","unstructured":"Ma X, Xu L, Alberobello AT.  Celastrol protects against obesity and metabolic dysfunction through activation of a HSF1-PGC1\u03b1 transcriptional axis.","journal-title":"Cell Metab"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.09.043","volume":"744","author":"Wang C.","year":"2014","unstructured":"Wang C, Shi C, Yang X, Yang M, Sun H, Wang C.  Celastrol suppresses obesity process  increasing antioxidant capacity and improving lipid metabolism.","journal-title":"Eur J Pharmacol"},{"key":"ref=25","author":"Han L.P.","year":"2016","unstructured":"Han LP, Li CJ, Sun B.  Protective effects of celastrol on diabetic liver injury  TLR4\/MyD88\/NF-\u03baB signaling pathway in type 2 diabetic rats.","journal-title":"J Diabetes Res"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2018.05.019","volume":"128","author":"Kashyap D.","year":"2018","unstructured":"Kashyap D, Sharma A, Tuli HS, Sak K, Mukherjee T, Bishayee A.  Molecular targets of celastrol in cancer: Recent trends and advancements.","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-016-0516-8","volume":"13","author":"Bian M.","year":"2016","unstructured":"Bian M, Du X, Cui J.  Celastrol protects mouse retinas from bright light-induced degeneration through inhibition of oxidative stress and inflammation.","journal-title":"J Neuroinflammation"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bph.13655","volume":"174","author":"Zhang R.","year":"2017","unstructured":"Zhang R, Zhang N, Zhang H.  Celastrol prevents cadmium-induced neuronal cell death by blocking reactive oxygen species-mediated mammalian target of rapamycin pathway.","journal-title":"Br J Pharmacol"},{"key":"ref=29","first-page":"685","volume":"16","author":"Han X-B.","year":"2018","unstructured":"Han X-B, Tan Y, Fang Y-Q, Li F.  Protective effects of celastrol against \u03b3 irradiation-induced oxidative stress in human umbilical vein endothelial cells.","journal-title":"Exp Ther Med"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1089\/ars.2010.3222","volume":"13","author":"Itoh K.","year":"2010","unstructured":"Itoh K, Mimura J, Yamamoto M.  Discovery of the negative regulator of Nrf2, Keap1: a historical overview.","journal-title":"Antioxid Redox Signal"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"Kobayashi A.","year":"2004","unstructured":"Kobayashi A, Kang MI, Okawa H.  Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.","journal-title":"Mol Cell Biol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","volume":"401","author":"Vriend J.","year":"2015","unstructured":"Vriend J, Reiter RJ.  The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome.","journal-title":"Mol Cell Endocrinol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","volume":"47","author":"Kaspar J.W.","year":"2009","unstructured":"Kaspar JW, Niture SK, Jaiswal AK.  Nrf2:INrf2 (Keap1) signaling in oxidative stress.","journal-title":"Free Radic Biol Med"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3109\/10715762.2010.507670","volume":"44","author":"Singh S.","year":"2010","unstructured":"Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P.  Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.","journal-title":"Free Radic Res"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/diseases4040034","volume":"4","author":"Smith R.E.","year":"2016","unstructured":"Smith RE, Tran K, Smith CC, McDonald M, Shejwalkar P, Hara K.  The role of the Nrf2\/ARE antioxidant system in preventing cardiovascular diseases.","journal-title":"Diseases"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2011.03.053","volume":"407","author":"Seo W.Y.","year":"2011","unstructured":"Seo WY, Goh AR, Ju SM.  Celastrol induces expression of heme oxygenase-1 through ROS\/Nrf2\/ARE signaling in the HaCaT cells.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2017.01.027","volume":"797","author":"Li M.","year":"2017","unstructured":"Li M, Liu X, He Y.  Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation of Nrf2\/ERK1\/2\/Nox2 signal pathway.","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cbi.2016.01.006","volume":"246","author":"Divya T.","year":"2016","unstructured":"Divya T, Dineshbabu V, Soumyakrishnan S, Sureshkumar A, Sudhandiran G.  Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis.","journal-title":"Chem Biol Interact"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0278-5846(01)00192-0","volume":"25","author":"Allison A.C.","year":"2001","unstructured":"Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C.  Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-016-0516-8","volume":"13","author":"Bian M.","year":"2016","unstructured":"Bian M, Du X, Cui J.  Celastrol protects mouse retinas from bright light-induced degeneration through inhibition of oxidative stress and inflammation.","journal-title":"J Neuroinflammation"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3892\/ijmm.2016.2549","volume":"37","author":"Guan Y.","year":"2016","unstructured":"Guan Y, Cui ZJ, Sun B, Han LP, Li CJ, Chen LM.  Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1\u03b1-SIRT3 signaling pathway.","journal-title":"Int J Mol Med"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.freeradbiomed.2010.09.021","volume":"49","author":"Loor G.","year":"2010","unstructured":"Loor G, Kondapalli J, Schriewer JM, Chandel NS, Vanden Hoek TL, Schumacker PT.  Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis.","journal-title":"Free Radic Biol Med"},{"key":"ref=43","doi-asserted-by":"crossref","unstructured":"Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med 2015; 88(Pt B): 314-36.","DOI":"10.1016\/j.freeradbiomed.2015.05.036"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1002\/jcb.28326","volume":"120","author":"Du Z.","year":"2019","unstructured":"Du Z, Zhang W, Wang S.  Celastrol protects human retinal pigment epithelial cells against hydrogen peroxide mediated oxidative stress, autophagy, and apoptosis through sirtuin 3 signal pathway.","journal-title":"J Cell Biochem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.7.3.2","volume":"7","author":"Tode J.","year":"2018","unstructured":"Tode J, Richert E, Koinzer S.  Thermal stimulation of the retina reduces Bruch\u2019s membrane thickness in age related macular degeneration mouse models.","journal-title":"Transl Vis Sci Technol"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:41:59Z","timestamp":1568940119000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171829\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190424131704","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}